Healthcare & Life Sciences
Mysthera Therapeutics AG
Switzerland
seed
seed
Stage
1
Investors
About
Develops therapeutics for chronic autoimmune diseases associated with multicellular pathology and tertiary lymphoid structures.
Explore Mysthera Therapeutics AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.